31
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Chemical genetic analysis of signal transduction pathways

&
Pages 485-488 | Published online: 18 Jul 2006

Bibliography

  • BISHOP AC, UBERSAX JA, PETSCH DT et al.: A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature (2000) 407(6802):395-401.
  • BISHOP AC, BUZKO O, SHOKAT KM: Magic bullets for protein kinases. Trends Cell Biol. (2001) 11(4):167-172.
  • BISHOP AC, SHOKAT KM: Acquisition of inhibitor-sensitive protein kinases through protein design. Pharmacol. Ther. (1999) 82(2-3):337-346.
  • KNIGHT ZA, SHOKAT KM: Features of selective kinase inhibitors. Chem. Biol. (2005) 12(6):621-637.
  • ALAIMO PJ, KNIGHT ZA, SHOKAT KM: Targeting the gatekeeper residue in phosphoinositide 3-kinases. Bioorg. Med. Chem. (2005) 13(8):2825-2836.
  • COHEN MS, ZHANG C, SHOKAT KM, TAUNTON J: Structural bioinformatics-based design of selective, irreversible kinase inhibitors. Science (2005) 308(5726):1318-1321.
  • ZHANG C, KENSKI DM, PAULSON JL et al.: A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases. Nat. Methods (2005) 2(6):435-441.
  • PAPA FR, ZHANG C, SHOKAT K, WALTER P: Bypassing a kinase activity with an ATP-competitive drug. Science (2003) 302(5650): 1533-1537.
  • ABELIOVICH H, ZHANG C, DUNN WA Jr, SHOKAT KM, KLIONSKY DJ: Chemical genetic analysis of Apg1 reveals a non-kinase role in the induction of autophagy. Mol. Biol. Cell (2003) 14(2):477-490.
  • WEISS EL, BISHOP AC, SHOKAT KM, DRUBIN DG: Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4p. Nat. Cell Biol. (2000) 2(10):677-685.
  • SREENIVASAN A, BISHOP AC, SHOKAT KM, KELLOGG DR: Specific inhibition of Elm1 kinase activity reveals functions required for early G1 events. Mol. Cell Biol. (2003) 23(17):6327-6337.
  • CARROLL AS, BISHOP AC, DERISI JL, SHOKAT KM, O’SHEA EK: Chemical inhibition of the Pho85 cyclin-dependent kinase reveals a role in the environmental stress response. Proc. Natl. Acad. Sci. USA (2001) 98(22):12578-12583.
  • VENTURA JJ, HUBNER A, ZHANG C, FLAVELL RA, SHOKAT KM, DAVIS RJ: Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell (2006) 21(5):701-710.
  • EBLEN ST, KUMAR NV, SHAH K et al.: Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J. Biol. Chem. (2003) 278(17):14926-14935.
  • HABELHAH H, SHAH K, HUANG L, BURLINGAME AL, SHOKAT KM, RONAI Z: Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J. Biol. Chem. (2001) 276(21):18090-18095.
  • FAN QW, SPECHT KM, ZHANG C, GOLDENBERG DD, SHOKAT KM, WEISS WA: Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach. Cancer Res. (2003) 63(24):8930-8938.
  • FAN QW, ZHANG C, SHOKAT KM, WEISS WA: Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling. Curr. Biol. (2002) 12(16):1386-1394.
  • WONG S, WITTE ON: The BCR-ABL story: bench to bedside and back. Ann. Rev. Immunol. (2004) 22:247-306.
  • WONG S, MCLAUGHLIN J, CHENG D, ZHANG C, SHOKAT KM, WITTE ON: Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations. Proc. Natl. Acad. Sci. USA (2004) 101(50):17456-17461.
  • KUNG C, SHOKAT KM: Small-molecule kinase-inhibitor target assessment. Chembiochem (2005) 6(3):523-526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.